Fox Run Management L.L.C. lifted its stake in Enhabit, Inc. (NYSE:EHAB – Free Report) by 290.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,237 shares of the company’s stock after purchasing an additional 31,412 shares during the quarter. Fox Run Management L.L.C.’s holdings in Enhabit were worth $330,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in EHAB. Victory Capital Management Inc. bought a new stake in Enhabit in the third quarter worth $239,000. Intech Investment Management LLC bought a new stake in Enhabit during the 3rd quarter valued at about $96,000. Dynamic Technology Lab Private Ltd purchased a new position in Enhabit in the third quarter worth about $215,000. DRW Securities LLC bought a new position in shares of Enhabit in the third quarter worth approximately $326,000. Finally, FMR LLC grew its holdings in shares of Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after buying an additional 1,967 shares during the last quarter.
Enhabit Price Performance
EHAB opened at $8.80 on Thursday. The company’s 50-day simple moving average is $8.47 and its two-hundred day simple moving average is $7.96. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.74. The stock has a market capitalization of $444.22 million, a P/E ratio of -3.79 and a beta of 1.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on Enhabit
Enhabit Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
See Also
- Five stocks we like better than Enhabit
- Earnings Per Share Calculator: How to Calculate EPS
- Energy Transfer: Powering Data With Dividends and Diversification
- How to invest in marijuana stocks in 7 steps
- Qualcomm Stock Is Coiling for a Breakout
- What Does a Stock Split Mean?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Free Report).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.